Skip to: Content
Skip to: Site Navigation
Skip to: Search

May 17, 2008 1:19:42 AM CDT

Learn about Newser Points »

Back to the grid

Doc: Merck Fudged Minutes of Meeting  

Posted Apr 12, 08 9:33 AM CDT in Politics,  Science & Health,  Business    Most Covered

(newser) – Merck's "minutes" of a meeting of heart doctors discussing cholesterol drug Vytorin were created a month after the meeting and distorted the viewpoints of the experts, one panel member changes. The drug company submitted the document to congressional investigators probing its two-year delay in releasing a report saying the drug didn't work any better than a much cheaper generic one, Bloomberg reports.

The minutes say the panel unanimously chose to change the study's objective, a decision the company made, and then withdrew, when experts called it unethical. But the doctor says the panel—who had been assured no minutes were being taken—merely discussed the pros and cons of such a move and didn't make any formal recommendations.

Source Bloomberg

open commentscomments (0)

Editor Recommended

House skeptical of Merck's minutes
CNN | Apr 11, 08

Serious concerns raised over study's delay
Forbes | Apr 11, 08

Related News

  • Congress to Probe 'Misleading' Drug Ads

    May 8, 08 3:10 AM CDT
    Congress to Probe 'Misleading' Drug Ads A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug despite FDA demands not to do so. More »

  • Firms Hid Bad News on Heart Drugs 2 Years: Doc

    Apr 1, 08 10:49 AM CDT
    Firms Hid Bad News on Heart Drugs 2 Years: Doc A scientist hired by two drug companies to conduct trials of cholesterol-lowering drugs accused the firms of deliberately delaying release of the results, the New York Times reports. The results for the Vytorin and Zetia trials—which showed the drugs don't work to reduce plaque in arteries—were not released until almost two years after the medical trials wrapped up.  More »

  • 2 Top Cholesterol Drugs, Vytorin and Zetia, Don't Work

    Mar 31, 08 3:55 AM CDT
    2 Top Cholesterol Drugs, Vytorin and Zetia, Don't Work Two top-selling cholesterol drugs  proved in a recent study to be largely ineffective in slowing the clogging of arteries, a panel of cardiologists said yesterday. Doctors should only prescribe Vytorin and Zetia if other medications don't work, and should rely instead on statins such as Lipitor and Zocor, they said. “The strongest recommendation we can make is to go back to statins,” said one of the doctors. “They work.” More »

  • Generic Beats Pricey Pill on Cholesterol

    Jan 14, 08 5:42 PM CST
    Generic Beats Pricey Pill on Cholesterol A cheap generic drug cuts arterial buildup as well as a pricey pill and may threaten the growth of two drug companies, Bloomberg reports. Vytorin is produced by Merck & Co. and Schering-Plough Corp. and costs $2.84 per dose; simvastin, a generic, costs 3 cents a pill and works just as well, according to a new study. Stocks fell for both companies after the news broke today. More »

Doc: Merck Fudged Minutes of Meeting
Chairman of the board of the German pharmaceutical and chemical company Merck, Karl-Ludwig Kley, speaks during the annual shareholders meeting in Frankfurt, central Germany, Friday, March 28, 2008.   (AP Photo/Bernd Kammerer)
Doc: Merck Fudged Minutes of Meeting
The cholesterol-lowering drug Vytorin, is shown in this undated photo provided by Schering-Plough Corp. Merck & Co.   (AP Photo)
Doc: Merck Fudged Minutes of Meeting
An employee walks past a stained-glass window, bearing Merck & Co.'s name, as he walks to the elevator at the company's headquarters in a Whitehouse Station, N.J. file photo.   (AP Photo/Daniel Hulshizer, File)
prev   next
play

Threads (1 of 2)

Tags

pharmaceutical companies  • Merck  • drug companies  • clinical trials  • Vytorin  • Schering Plough  • cholesterol lowering drug


Loading...

Loading...

Related Threads: Pharma Misbehaving, Drug Companies

Next story from this section »

Today's Most Popular

Loading...

Other Business Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »